Related Experiment Video
Updated: Nov 4, 2025

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Association between anti-complement factor H antibodies and renal outcome in primary membranous nephropathy
Insights
Elevated anti-complement factor H (CFH) antibodies are prevalent in primary membranous nephropathy (MN) patients. Higher anti-CFH antibody levels independently predict worse kidney function in MN.
Area of Science:
- Nephrology
- Immunology
- Complement System
Background:
- Complement factor H (CFH) regulates the alternative complement pathway.
- The role of anti-CFH antibodies in primary membranous nephropathy (MN) is not well understood.
Purpose of the Study:
- To investigate the prevalence of anti-CFH antibodies in primary MN patients.
- To determine the association between anti-CFH antibodies and clinical outcomes in MN.
Main Methods:
- Retrospective study of 106 kidney disease patients (36 primary MN) and 18 healthy controls.
- Serum anti-CFH antibody titers measured using enzyme-linked immunosorbent assay (ELISA).
- Cox proportional hazards analysis used to assess predictors of renal dysfunction.
Main Results:
- Anti-CFH antibodies were detected in 77.8% of primary MN patients, significantly higher than controls.
- Median anti-CFH antibody titers were significantly elevated in MN patients compared to all control groups.
- Anti-CFH antibody titer was an independent predictor of unfavorable renal function.
Conclusions:
- Anti-CFH antibodies are frequently present in primary MN.
- These antibodies may contribute to the worsening of kidney function in primary MN patients.
Aims:
The complement factor H (CFH) is a regulator for the alternative complement pathway. The prevalence and roles of anti-CFH antibodies in the clinical outcome of primary membranous nephropathy (MN) patients remain unclear.
Materials And Methods:
A total of 106 biopsy-proven kidney disease patients and 18 healthy controls were retrospectively investigated in this study. 36 patients had primary MN and 70 patients were diseased controls (31 minimal change nephrotic syndrome (MCNS), 19 rapidly progressive glomerulonephritis (RPGN), and 20 IgA glomerulonephritis (IgAGN)). Serum anti-CFH antibody titers were measured by enzyme-linked immunosorbent assay.
Results:
77.8% of MN patients were positive for anti-CFH antibodies. However, only 27.1% of diseased control patients and 5.6% of healthy controls were positive for anti-CFH antibodies. Moreover, median anti-CFH antibody titers were significantly higher in MN patients (4.69 AU/mL) than in diseased control patients (MCNS patients (0 AU/mL, p < 0.01), RPGN patients (0 AU/mL, p < 0.05), IgAGN patients (0 AU/mL, p < 0.01)), and healthy controls (0 AU/mL, p < 0.01). Anti-CFH antibody titer was selected as an independent unfavorable predictor of renal dysfunction by Cox proportional hazards analysis.
Conclusion:
These data suggest that anti-CFH antibodies may be involved in the deterioration of renal function in primary MN.
More Related Videos
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
06:29Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
Published on: January 29, 2014
Related Concept Videos
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Acute Kidney Injury II: Pathophysiology